USANA Health Sciences (NYSE:USNA) Cut to Hold at Zacks Research

Zacks Research lowered shares of USANA Health Sciences (NYSE:USNA) from a strong-buy rating to a hold rating in a research report sent to investors on Monday,Zacks.com reports.

USANA Health Sciences Price Performance

Shares of USNA opened at $28.95 on Monday. The firm has a 50-day simple moving average of $30.68 and a two-hundred day simple moving average of $29.49. The stock has a market cap of $528.90 million, a PE ratio of 16.08, a P/E/G ratio of 0.92 and a beta of 0.64. USANA Health Sciences has a 1-year low of $23.10 and a 1-year high of $41.83.

USANA Health Sciences (NYSE:USNA) last posted its quarterly earnings data on Tuesday, July 22nd. The company reported $0.74 earnings per share for the quarter, topping analysts’ consensus estimates of $0.54 by $0.20. The firm had revenue of $235.85 million during the quarter, compared to analysts’ expectations of $225.20 million. USANA Health Sciences had a net margin of 3.79% and a return on equity of 9.48%. USANA Health Sciences has set its FY 2025 guidance at 2.350-3.000 EPS. As a group, sell-side analysts expect that USANA Health Sciences will post 2.45 earnings per share for the current fiscal year.

Insider Buying and Selling at USANA Health Sciences

In other USANA Health Sciences news, Director Gilbert A. Fuller sold 1,058 shares of USANA Health Sciences stock in a transaction dated Thursday, August 7th. The stock was sold at an average price of $29.10, for a total value of $30,787.80. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. Also, insider David Mulham Mulham sold 3,515 shares of the stock in a transaction dated Wednesday, July 30th. The stock was sold at an average price of $30.26, for a total transaction of $106,363.90. Following the sale, the insider directly owned 9,260 shares in the company, valued at $280,207.60. This represents a 27.51% decrease in their position. The disclosure for this sale can be found here. 0.63% of the stock is currently owned by insiders.

Institutional Inflows and Outflows

A number of institutional investors have recently made changes to their positions in the business. Pzena Investment Management LLC increased its holdings in USANA Health Sciences by 9.4% during the 2nd quarter. Pzena Investment Management LLC now owns 1,198,260 shares of the company’s stock worth $36,583,000 after purchasing an additional 103,074 shares during the period. Connor Clark & Lunn Investment Management Ltd. boosted its stake in shares of USANA Health Sciences by 202.3% in the 2nd quarter. Connor Clark & Lunn Investment Management Ltd. now owns 97,537 shares of the company’s stock valued at $2,978,000 after buying an additional 65,268 shares during the period. Jacobs Levy Equity Management Inc. grew its position in shares of USANA Health Sciences by 46.2% during the first quarter. Jacobs Levy Equity Management Inc. now owns 188,511 shares of the company’s stock worth $5,084,000 after buying an additional 59,535 shares in the last quarter. Ameriprise Financial Inc. increased its stake in shares of USANA Health Sciences by 64.6% during the second quarter. Ameriprise Financial Inc. now owns 150,090 shares of the company’s stock worth $4,582,000 after buying an additional 58,921 shares during the period. Finally, Nuveen LLC purchased a new stake in shares of USANA Health Sciences during the first quarter worth approximately $895,000. Institutional investors and hedge funds own 54.25% of the company’s stock.

About USANA Health Sciences

USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.